Deutsche Bank reiterated coverage on Westlake Chemical with a new price target
$WLKP
Major Chemicals
Industrials
Deutsche Bank reiterated coverage of Westlake Chemical with a rating of Buy and set a new price target of $31.00 from $30.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/2/2022 | $30.00 → $31.00 | Buy | Deutsche Bank |
| 7/16/2021 | $27.00 | Buy → Underperform | BofA Securities |
10-Q - Westlake Chemical Partners LP (0001604665) (Filer)
8-K - Westlake Chemical Partners LP (0001604665) (Filer)
144 - Westlake Chemical Partners LP (0001604665) (Subject)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4/A - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4/A - Westlake Chemical Partners LP (0001604665) (Issuer)
Deutsche Bank reiterated coverage of Westlake Chemical with a rating of Buy and set a new price target of $31.00 from $30.00 previously
BofA Securities downgraded Westlake Chemical Partners from Buy to Underperform and set a new price target of $27.00
UBS downgraded Westlake Chemical from Buy to Neutral and set a new price target of $25.00 from $23.00 previously
Renewed Ethylene Sales Agreement through 2027 at existing terms Declared quarterly distribution of $0.4714 per unit; 45th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2025 of $14.7 million, or $0.42 per limited partner unit, which was below third quarter 2024 net income of $18.1 million. Cash flows from operating activities in the third quarter of 2025 were $105.2 million, a decrease of $20.9 million compared to third quarter 2024 cash flows from operating activities of $126.1 million. For the three months ended September 30, 2025, MLP distributable ca
Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") announced that Westlake Chemical OpCo LP ("OpCo") and Westlake Corporation ("Westlake") agreed to renew the Ethylene Sales Agreement between the parties through December 31, 2027 in accordance with its terms, which provides for an initial term through December 31, 2026 and automatic 12-month renewal periods until terminated at the end of the initial term or any renewal term on not less than 12-months' notice. The renewal of the Ethylene Sales Agreement will facilitate continued offtake on attractive terms for 95% of the ethylene produced by OpCo. The renewed agreement maintains the same pricing formula and sales volume protecti
$0.4714 per unit distribution declared payable on November 26, 2025 The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 45th quarterly distribution announced by the Partnership since its initial public offering. The distribution will be payable on November 26, 2025, to unit holders of record on November 10, 2025. This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as be
Renewed Ethylene Sales Agreement through 2027 at existing terms Declared quarterly distribution of $0.4714 per unit; 45th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2025 of $14.7 million, or $0.42 per limited partner unit, which was below third quarter 2024 net income of $18.1 million. Cash flows from operating activities in the third quarter of 2025 were $105.2 million, a decrease of $20.9 million compared to third quarter 2024 cash flows from operating activities of $126.1 million. For the three months ended September 30, 2025, MLP distributable ca
Westlake Chemical Partners (NYSE:WLKP) will release its third quarter 2025 earnings prior to the market opening on Thursday, October 30, 2025. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI18a27e98796e4538920bcc251d12d94a. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/zo2bvgiu
Declared quarterly distribution of $0.4714 per unit; 44th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2025 of $14.6 million, or $0.41 per limited partner unit, which was in line with second quarter 2024 net income of $14.4 million. Cash flows from operating activities in the second quarter of 2025 were $9.1 million, a decrease of $112.8 million compared to second quarter 2024 cash flows from operating activities of $121.9 million. For the three months ended June 30, 2025, MLP distributable cash flow was $15.0 million, a decrease of $2.1 million compared
Westlake Chemical Partners (NYSE:WLKP) today announced that Ms. Lisa A. Friel has been appointed to the board of directors of its general partner, Westlake Chemical Partners GP LLC. She will replace Ms. Angela A. Minas, who previously informed the company that she would resign from the board effective upon the appointment of her successor. Ms. Friel was the Managing Partner of Ernst & Young LLP's San Antonio, Texas office from July 2012 until her retirement in September 2020. Ms. Friel began her career with Ernst & Young LLP in 1988. She is currently the Chair of the Board of Directors for the United Way of San Antonio. Ms. Friel holds a bachelor's of science degree in Accounting and Busi
Retirement of Dr Sarah Ryan and Dr Christopher Haynes from the Woodside BoardPERTH, AUSTRALIA / ACCESSWIRE / March 8, 2023 / The Board of Woodside announces the retirement of Dr Sarah Ryan and Dr Christopher Haynes as Directors of Woodside. Dr Ryan and Dr Haynes will be standing down from their respective offices with effect from the conclusion of Woodside's 2023 Annual General Meeting, scheduled to be held on 28 April 2023 (2023 AGM).Dr Haynes has served on Woodside's Board since 2011 and is a member of the Audit & Risk Committee, the Sustainability Committee and the Nominations & Governance Committee.Dr Ryan joined the Woodside Board in December 2012 and serves on the Audit & Risk Committe
Crestwood Equity Partners LP (NYSE:CEQP) ("Crestwood") announced today that Angela A. Minas and Clay C. Williams have been appointed to serve on the Board of Directors of its general partner effective January 1, 2022. "I am pleased to welcome Angela and Clay to the Crestwood Board of Directors. Both of these highly regarded individuals bring a wealth of U.S. and global industry experience and perspective to our boardroom that will greatly benefit Crestwood as we navigate the dynamic energy industry and take advantage of opportunities to continue building a leading midstream infrastructure company," said Robert G. Phillips, Chairman, President and Chief Executive Officer of Crestwood's gene
SC 13D/A - Westlake Chemical Partners LP (0001604665) (Subject)
SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)
SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)